ANGELA STEWART for EISAI, INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA STEWART New | Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner |
Budget/Appropriations BUD
Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA STEWART New | Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner |
Pharmacy PHA
Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA STEWART New | Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner |
Health Issues HCR
Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA STEWART New | Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.